Is Alterity Therapeutics Limited (ATHE) a Buy, Sell, or Hold?
NASDAQ : ATHE
Alterity Therapeutics Limited
$4.98 USD
-$0.1 (-2.06%)
- Volume
- 9.37K
- Average Volume
- 52.48K
- Market Capitalization
- $45.14M
- P/E Ratio
- -7.20
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $7.00
- Year Low
- $2.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.98
3333332"{?
p/.m7yd f,0=
Annual earnings financials
ATHE financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
ATHE Estimated and Actual Revenue by Quarter
ATHE Estimated and Actual EPS by Quarter
ATHE Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2025-12-31 | 1 | -1.08M | -1.08M | -1.08M | -1.08M | -1.08M | -1.08M |
| 2024-12-31 | 2 | -1.5M | -1.5M | -1.5M | -1.5M | -1.5M | -1.5M |
ATHE Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2025-12-31 | 1 | -11.9M | -11.9M | -11.9M | 1.33M | 1.33M | 1.33M |
| 2024-12-31 | 2 | - | - | - | 1.84M | 1.84M | 1.84M |
ATHE Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2025-12-31 | 1 | 1.08M | 1.08M | 1.08M | 1 | -0.70111 | -0.70111 | -0.70111 |
| 2024-12-31 | 2 | 1.5M | 1.5M | 1.5M | 0 | 0 | 0 | 0 |